Nektar Therapeutics
Work in HR? Unlock Free Profile

Nektar Therapeutics Reviews

25 Reviews
25 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Nektar Therapeutics President, CEO, and Director Howard W. Robin
Howard W. Robin
19 Ratings

    Rock solid pay, innovative environment, knowledgeable colleagues

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    Current Employee - Biochemist ( Senior Process Development Engineer)  in  Huntsville, AL
    Current Employee - Biochemist ( Senior Process Development Engineer) in Huntsville, AL

    I have been working at Nektar Therapeutics full-time for less than a year


    Rock solid pay, innovative environment, knowledgeable colleagues


    Business is uncertain due to market conditions.

    Positive Outlook
    Approves of CEO

Nektar Therapeutics Interviews

Updated Sep 11, 2014
Updated Sep 11, 2014

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Biochemist ( Senior Process Development Engineer) Interview

    Anonymous Interview Candidate  in  Huntsville, AL
    Anonymous Interview Candidate in Huntsville, AL
    Application Details

    I applied through a recruiter. The process took 3 weeks - interviewed at Nektar Therapeutics in April 2014.

    Interview Details

    I came to know about this position via a recruiter. There was initial phone interview with hiring manager. Was invited to the onsite after 2 weeks. Had 1:1 interview along with panel presentation. The interviews were all day long process. The onsite interview was followed by telephonic interview with upper management. Got the offer within 2 weeks.

    Interview Questions
    Negotiation Details
    They offered on the lower end of their scale. We met at the middle. Benefits and compensation are great, so no need to negotiate on that.
    Accepted Offer
    Positive Experience
    Average Interview

Nektar Therapeutics Awards & Accolades

Something missing? Add an award
Best Places to Work for Commuters, National Center for Transit Research at USF, 2012

Additional Info

Edit Profile
Headquarters San Francisco, CA
Size 150 to 499 Employees
Founded 1990
Type Company - Public (NKTR)
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

Nektar Therapeutics has pegged its fortunes to making drugs more effective. The clinical-stage drug development firm uses its PEGylation technology, (based upon polyethylene glycol) to improve the delivery and efficacy of existing drugs. Nektar's pipeline is focused on anti-infectives and anti-virals, immunology, oncology, and pain treatments. Its lead candidate NKTR-118 (which it is developing in collaboration with AstraZeneca) is being tested as a treatment for opioid-induced constipation. It also maintains a handful of preclinical candidates. Nektar receives royalties... More

Worked for Nektar Therapeutics? Contribute to the Community!